Kure Advisory’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$239K Buy
943
+30
+3% +$6.99K 0.11% 53
2026
Q1
$223K Sell
913
-184
-17% -$42.9K 0.12% 51
2025
Q4
$227K Buy
+1,097
New +$217K 0.13% 50
2024
Q1
Sell
-2,752
Closed -$431K 82
2023
Q4
$431K Buy
2,752
+141
+5% +$21.6K 0.22% 55
2023
Q3
$407K Buy
+2,611
New +$431K 0.23% 56

Other funds holding JNJ

Kure Advisory's JNJ Position: Q2 2026 in Review

Kure Advisory increased its Johnson & Johnson (JNJ) stake by 3.3% in Q2 2026, buying an estimated $6.99K and bringing the position to 943 shares worth $239K. The position accounts for 0.11% of the portfolio, ranked #53.

Kure Advisory first reported a position in JNJ in Q3 2023 and has held it in 5 quarters since. The position peaked at $431K in Q4 2023. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Kure Advisory held 943 shares of Johnson & Johnson worth $239K as of Q2 2026.
  • Kure Advisory bought 30 Johnson & Johnson shares in Q2 2026, an estimated $6.99K.
  • Johnson & Johnson made up 0.11% of Kure Advisory's portfolio in Q2 2026, its #53 holding.
  • Kure Advisory first reported a position in Johnson & Johnson in Q3 2023 and has held it in 5 quarters since.
  • Kure Advisory's Johnson & Johnson position peaked at $431K in Q4 2023.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Kure Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.